Effective radiotherapy dose for suspicious positive cervical lymph nodes for N 0 nasopharyngeal carcinoma patients : a prospective cohort study

Jun Lv,Lingjiang Pan,Jiamei Lu,Wen Qin,Tingting Zhang

2017-01-01

Abstract:Nasopharyngeal carcinoma (NPC) is a malignant tumor, with a high rate of incidence in Southern China. This study explored the most appropriate radiotherapy dose for suspicious positive cervical lymph nodes in patients with N0 NPC. Ninety-six patients with suspicious positive cervical lymph nodes were randomized into low-dose group (64 Gy) and high-dose group (68-70 Gy). Among these, T3/T4-stage patients were given concomitant chemoradiotherapy and were followed-up for 28-44 months, with a median of 36 months, during which the regression of cervical lymph nodes, radiation injury of cervical skin and muscle, regional control rate, distant metastases rate, overall survival (OS), and other indicators were observed. Intergroup comparisons were performed using t-test. The treatment efficiencies for suspicious positive cervical lymph nodes of the experiment and control groups were 90.1% and 93.3%, respectively (P < 0.05), and the incidences of cervical mucocutaneous reactions were 12.5% and 33.3% (P < 0.05), respectively. The 3-year OS rates of the groups were 93.5% and 89.1% (P < 0.05), respectively, while the tumor-free survival (TFS) rates were 87.0% and 80.4% (P < 0.05), respectively. Treatment efficiency of cervical lymph nodes, OS, and other indicators did not show significant differences between the two groups, while the incidences of radiation dermatitis of neck skin and cervical soft tissue fibrosis were significantly lower in the experiment group than the control group. Therefore, a radiotherapy dose of 64 Gy for suspicious positive cervical lymph nodes of NPC is safe and reliable.